|
Volumn 169, Issue 3, 2001, Pages 573-579
|
Dexamethasone enhances SOX9 expression in chondrocytes
a b a c c d a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORAMPHENICOL ACETYLTRANSFERASE;
COLLAGEN TYPE 2;
DEXAMETHASONE;
GLUCOCORTICOID;
MESSENGER RNA;
PROCOLLAGEN;
TESTIS DETERMINING FACTOR;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR SOX9;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CARTILAGE CELL;
CELL DIFFERENTIATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
GENE CONSTRUCT;
GENE EXPRESSION;
GENE SEQUENCE;
HALF LIFE TIME;
INTRON;
MOLECULAR WEIGHT;
MOUSE;
NEWBORN;
NONHUMAN;
PRIORITY JOURNAL;
RIB CARTILAGE;
WESTERN BLOTTING;
ANIMALS;
ANIMALS, NEWBORN;
ANTI-INFLAMMATORY AGENTS;
CELL CULTURE TECHNIQUES;
CELL DIFFERENTIATION;
CHONDROCYTES;
DEXAMETHASONE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GENE EXPRESSION REGULATION;
GLUCOCORTICOIDS;
HIGH MOBILITY GROUP PROTEINS;
MICE;
MICE, INBRED ICR;
PROCOLLAGEN;
RNA, MESSENGER;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
|
EID: 0034970523
PISSN: 00220795
EISSN: None
Source Type: Journal
DOI: 10.1677/joe.0.1690573 Document Type: Article |
Times cited : (66)
|
References (36)
|